197 related articles for article (PubMed ID: 31518873)
1. Regulatory roles of the miR-200 family in neurodegenerative diseases.
Fu J; Peng L; Tao T; Chen Y; Li Z; Li J
Biomed Pharmacother; 2019 Nov; 119():109409. PubMed ID: 31518873
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.
Sundararajan V; Burk UC; Bajdak-Rusinek K
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740906
[TBL] [Abstract][Full Text] [Related]
3. microRNA dysregulation in neurodegenerative diseases: A systematic review.
Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in neurodegenerative diseases: a review.
Li S; Lei Z; Sun T
Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
[TBL] [Abstract][Full Text] [Related]
5. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
6. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
7. GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases.
Gizak A; Duda P; Pielka E; McCubrey JA; Rakus D
Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118696. PubMed ID: 32165184
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
9. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer.
Indrieri A; Carrella S; Carotenuto P; Banfi S; Franco B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197476
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
11. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative Disorders Treatment: The MicroRNA Role.
Ridolfi B; Abdel-Haq H
Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
Saraiva C; Esteves M; Bernardino L
Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
[TBL] [Abstract][Full Text] [Related]
17. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in glaucoma and neurodegenerative diseases.
Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
[TBL] [Abstract][Full Text] [Related]
19. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
